Basel, Switzerland, October 08, 2025 – NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, today announced positive clinical data from the ongoing Phase I/II trial (NCT06455358) evaluating its novel copper-radiolabeled PET tracer, 61Cu-TraceNetTM ([61Cu]Cu-NODAGA-LM3) in patients with SSTR-positive gastroenteropancreatic and bronchopulmonary neuroendocrine tumors (GEP & BP-NETS). Principal investigator Dr. Guillaume Nicolas,…
ENCINO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a provider of AI-powered solutions and services enabling OEMs, dealerships and financial institutions to sell, finance and lease assets, announced the launch of Check AI – its next-generation AI-powered credit decisioning engine designed to revolutionize the credit underwriting process.
MILANO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), azienda biofarmaceutica focalizzata sullo sviluppo e la commercializzazione di nuove terapie per malattie genetiche rare e ultra-rare, ha annunciato oggi che l'AIFA (Agenzia Italiana del Farmaco) ha esteso il rimborso di Evkeeza® (evinacumab) per il trattamento di pazienti pediatrici a partire dai 6…
Publicly listed real estate developer Hepsor, in cooperation with LHV Pank, is preparing a bond programme and plans to list the bonds on the main list of the Nasdaq Tallinn Stock Exchange in order to diversify the company’s financing structure and ensure capital for funding projects in its diversified portfolio across its home markets.
NEW YORK CITY and NEW ORLEANS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 13, 2025 to file lead plaintiff applications in a securities class action lawsuit against KinderCare Learning Companies, Inc. (NYSE:…
